It Is Not Always Alcohol Abuse--A Transferrin Variant Impairing the CDT Test

Alcohol Alcohol. 2016 Mar;51(2):148-53. doi: 10.1093/alcalc/agv099. Epub 2015 Sep 1.

Abstract

Aims: Elevated Carbohydrate-deficient transferrin (CDT) levels are used as a biomarker in order to screen for chronic alcohol abuse. Transferrin (Tf) variants can impair methods to measure elevated CDT levels such as high-performance liquid chromatography (HPLC). We present a Tf variant affecting the second glycosylation site of Tf and the complications it causes in diagnosing alcoholism.

Methods: A blood sample from a patient with suspected alcohol abuse was analyzed with HPLC, isoelectric focusing, electrospray ionization time-of-flight mass spectrometry (ESI-TOF-MS), immunoprecipitation and SDS-Page. Sanger sequencing of Tf was performed to detect Tf mutations.

Results: HPLC, SDS-Page and IEF showed a distinctly increased disialo-Tf fraction while the tetrasialo-Tf fraction was decreased, ESI-TOF-MS confirmed these results. Sanger sequencing revealed the Tf mutation c.1889 A>C, deleting a Tf glycosylations site and thereby causing elevated disialo-Tf levels.

Conclusions: Transferrin mutations can severely impair the diagnostics of chronic alcohol abuse by causing false positive results. This has to be considered when CDT screening is used to detect alcoholism.

MeSH terms

  • Alcoholism / diagnosis*
  • Alcoholism / genetics*
  • Biomarkers / analysis
  • Chromatography, High Pressure Liquid / methods
  • Genetic Variation / genetics*
  • Humans
  • Mutation / genetics*
  • Spectrometry, Mass, Electrospray Ionization / methods
  • Transferrin / analogs & derivatives
  • Transferrin / analysis
  • Transferrin / genetics*

Substances

  • Biomarkers
  • Transferrin
  • carbohydrate-deficient transferrin